Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.55%200.36B | -4.48%946.78B | -11.13%300.47B | 5.61%246.75B | -11.47%198.09B | 2.98%201.47B | 10.73%991.14B | 8.20%338.11B | 10.37%233.65B | 12.70%223.75B |
Cost of revenue | -0.86%111.31B | -5.95%552.6B | -12.78%184.39B | 7.30%143.74B | -14.35%112.19B | 0.95%112.28B | 15.67%587.57B | 14.42%211.42B | 12.62%133.96B | 18.93%130.98B |
Gross profit | -0.15%89.05B | -2.33%394.17B | -8.38%116.07B | 3.33%103.01B | -7.40%85.9B | 5.65%89.19B | 4.26%403.56B | -0.80%126.69B | 7.48%99.69B | 4.95%92.76B |
Operating expense | -0.67%84.85B | 3.37%359.88B | -9.27%97.41B | 5.48%88.73B | 5.51%88.32B | 17.08%85.42B | 10.37%348.15B | 3.61%107.36B | 14.53%84.12B | 15.90%83.71B |
Staff costs | -1.94%46.61B | 1.75%194.43B | -14.52%50.48B | 5.62%47.55B | 7.66%48.87B | 14.19%47.54B | 4.06%191.09B | -7.45%59.05B | 13.22%45.02B | 10.13%45.39B |
Depreciation and amortization | 11.74%3.27B | -3.15%12.62B | 10.14%3.38B | 0.13%3.09B | -36.14%3.23B | 60.28%2.93B | 29.73%13.03B | 55.08%3.07B | -4.08%3.08B | 63.48%5.06B |
-Depreciation | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Amortization | 11.74%3.27B | -3.15%12.62B | 10.14%3.38B | 0.13%3.09B | -36.14%3.23B | 60.28%2.93B | 29.73%13.03B | 55.08%3.07B | -4.08%3.08B | 63.48%5.06B |
Other operating expenses | 0.02%34.96B | 6.11%152.83B | -3.73%43.56B | 5.76%38.09B | 8.91%36.23B | 18.47%34.95B | 18.28%144.03B | 19.59%45.25B | 18.20%36.02B | 19.13%33.26B |
Operating profit | 11.61%4.21B | -38.11%34.29B | -3.45%18.66B | -8.27%14.28B | -126.74%-2.42B | -67.10%3.77B | -22.66%55.41B | -19.76%19.33B | -19.36%15.57B | -43.98%9.05B |
Net non-operating interest income (expenses) | -336.73%-116M | -177.87%-653M | 83.91%-28M | -679.49%-304M | -3,600.00%-370M | 508.33%49M | -27.03%-235M | -427.27%-174M | 23.53%-39M | 72.22%-10M |
Non-operating interest income | -1.51%196M | 11.72%486M | -5.04%113M | -14.84%109M | -19.75%65M | 85.98%199M | -9.38%435M | -53.70%119M | 70.67%128M | -12.90%81M |
Non-operating interest expense | 108.00%312M | 70.00%1.14B | -51.88%141M | 147.31%413M | 378.02%435M | 26.05%150M | 0.75%670M | 1.03%293M | 32.54%167M | -29.46%91M |
Net investment income | 9.11%2.23B | 14.81%3.64B | 1,223.76%1.34B | -197.30%-396M | 2.83%653M | 0.89%2.04B | 39.84%3.17B | -70.72%101M | -47.89%407M | 198.12%635M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -141.82%-230M | 12,495.06%20.4B | 2,090.69%23.09B | 628.33%317M | -446.15%-3.56B | 54.93%550M | -99.32%162M | -105.07%-1.16B | -123.17%-60M | 533.95%1.03B |
Income from associates and other participating interests | -163.64%-174M | -967.01%-2.07B | -8,150.00%-1.93B | -56.00%33M | -138.64%-105M | 73.49%-66M | -107.44%-194M | -99.09%24M | -29.25%75M | -238.46%-44M |
Special income (charges) | -5.77%-715M | -291.23%-7.54B | -43.59%-3.05B | -1,919.64%-2.26B | -419.59%-1.55B | -281.92%-676M | 55.34%-1.93B | -509.65%-2.12B | 97.55%-112M | 256.45%485M |
Less:Restructuring and mergern&acquisition | --738M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---332M | ---- |
Less:Other special charges | -103.40%-23M | 409.40%6.07B | 138.97%2.19B | 444.85%2.22B | 415.81%979M | 281.92%676M | -70.14%1.19B | 208.66%916M | -91.09%408M | -200.00%-310M |
Less:Write off | ---- | 99.73%1.47B | 22.75%858M | 8.33%39M | ---- | ---- | 126.15%735M | 115.08%699M | --36M | ---- |
Other non-operating income (expenses) | -71.17%190M | 15.49%3.27B | 21.32%2.9B | 28.76%-161M | -126.28%-128M | 266.11%659M | 390.35%2.83B | 236.24%2.39B | -162.95%-226M | 101.24%487M |
Income before tax | -14.80%5.39B | -13.30%51.33B | 122.92%40.98B | -26.31%11.51B | -164.26%-7.48B | -53.40%6.33B | -37.48%59.21B | -62.24%18.38B | -3.50%15.62B | -29.13%11.64B |
Income tax | -26.29%4.03B | -4.59%24.54B | 45.27%10.68B | -9.52%5.81B | -39.68%2.59B | -28.66%5.46B | -28.24%25.72B | -53.58%7.35B | -6.37%6.43B | -40.05%4.29B |
Net income | 58.00%1.36B | -19.99%26.79B | 174.61%30.3B | -38.02%5.7B | -237.05%-10.07B | -85.43%862M | -43.11%33.49B | -66.41%11.03B | -1.42%9.19B | -20.70%7.35B |
Net income continuous operations | 57.94%1.36B | -19.99%26.79B | 174.65%30.3B | -38.04%5.69B | -237.06%-10.07B | -85.42%863M | -43.11%33.49B | -66.41%11.03B | -1.39%9.19B | -20.70%7.35B |
Noncontrolling interests | -36.92%1.04B | -24.52%1.87B | -57.06%73M | -83.09%128M | -93.90%13M | 23.88%1.66B | -32.77%2.48B | -78.01%170M | -2.20%757M | -77.41%213M |
Net income attributable to the company | 139.97%317M | -19.63%24.92B | 178.22%30.23B | -33.99%5.57B | -241.34%-10.08B | -117.31%-793M | -43.80%31.01B | -66.13%10.87B | -1.33%8.43B | -14.28%7.13B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 139.97%317M | -19.63%24.92B | 178.22%30.23B | -33.99%5.57B | -241.34%-10.08B | -117.31%-793M | -43.80%31.01B | -66.13%10.87B | -1.33%8.43B | -14.28%7.13B |
Gross dividend payment | ||||||||||
Basic earnings per share | 139.98%0.8635 | -18.39%67.87 | 181.53%82.32 | -32.91%15.15 | -243.82%-27.44 | -117.62%-2.16 | -43.70%83.16 | -65.94%29.24 | -1.27%22.58 | -14.32%19.08 |
Diluted earnings per share | 139.98%0.8635 | -18.40%67.86 | 181.53%82.32 | -32.88%15.15 | -243.97%-27.4692 | -117.62%-2.16 | -43.69%83.16 | -65.94%29.24 | -1.31%22.57 | -14.32%19.08 |
Dividend per share | 0 | 0.00%32 | 0.00%16 | 0 | 0.00%16 | 0 | 0.00%32 | -5.88%16 | 0 | 6.67%16 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |